{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:11:47Z","timestamp":1783973507339,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["2R44HL142418\\u201302"],"award-info":[{"award-number":["2R44HL142418\\u201302"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["1R43AI129444"],"award-info":[{"award-number":["1R43AI129444"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jcyt.2025.102006","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:54:09Z","timestamp":1763693649000},"page":"102006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cryopreserved organ donor bone marrow achieves robust engraftment and chimerism in mismatched allogeneic transplantation"],"prefix":"10.1016","volume":"28","author":[{"given":"Erik J.","family":"Woods","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5387-720X","authenticated-orcid":false,"given":"Sagar","family":"Munjal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9936-6031","authenticated-orcid":false,"given":"Muneer H.","family":"Abidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7536-0623","authenticated-orcid":false,"given":"Jeremy","family":"Pantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki L.","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Blankenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Musall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preethi","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6706-8371","authenticated-orcid":false,"given":"W. Scott","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2112-3192","authenticated-orcid":false,"given":"Brian H.","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcyt.2025.102006_bib0001","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.jcyt.2025.102006_bib0002","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1200\/JCO.2012.48.0525","article-title":"Should cytoreductive treatment be performed before transplantation in patients with high-risk myelodysplastic syndrome?","volume":"31","author":"Alessandrino","year":"2013","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jcyt.2025.102006_bib0003","doi-asserted-by":"crossref","first-page":"95e1","DOI":"10.1016\/j.jtct.2022.11.010","article-title":"Characterization and function of cryopreserved bone marrow from deceased organ donors: a potential viable alternative graft source","volume":"29","author":"Johnstone","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"21","key":"10.1016\/j.jcyt.2025.102006_bib0004","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1200\/JCO.2012.46.8652","article-title":"Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis","volume":"31","author":"Koreth","year":"2013","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.jcyt.2025.102006_bib0005","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/bmt.2013.124","article-title":"Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML","volume":"48","author":"Ustun","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jcyt.2025.102006_bib0006","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM195709122571102","article-title":"Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy","volume":"257","author":"Thomas","year":"1957","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcyt.2025.102006_bib0007","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1182\/blood.V14.2.140.140","article-title":"The collection, storage and preparation of viable cadaver marrow for intravenous use","volume":"14","author":"Ferrebee","year":"1959","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jcyt.2025.102006_bib0008","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2991\/chi.k.210703.002","article-title":"History and development of autologous stem cell transplantation for acute myeloid leukemia","volume":"3","author":"Gorin","year":"2021","journal-title":"Clin Hematol Int"},{"key":"10.1016\/j.jcyt.2025.102006_bib0009","series-title":"Culture of animal cells: a manual of basic technique and specialized applications","author":"Freshney","year":"2015"},{"issue":"2","key":"10.1016\/j.jcyt.2025.102006_bib0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jtct.2020.10.014","article-title":"Meeting the demand for unrelated donors in the midst of the COVID-19 pandemic: rapid adaptations by the national marrow donor program and its network partners ensured a safe supply of donor products","volume":"27","author":"Auletta","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"19","key":"10.1016\/j.jcyt.2025.102006_bib0011","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1182\/bloodadvances.2023009786","article-title":"Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic","volume":"7","author":"Devine","year":"2023","journal-title":"Blood Adv"},{"issue":"17","key":"10.1016\/j.jcyt.2025.102006_bib0012","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1182\/bloodadvances.2020002431","article-title":"Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic","volume":"4","author":"Purtill","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102006_bib0013","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12967-020-02470-1","article-title":"Ischemia considerations for the development of an organ and tissue donor derived bone marrow bank","volume":"18","author":"Woods","year":"2020","journal-title":"J Transl Med"},{"issue":"6","key":"10.1016\/j.jcyt.2025.102006_bib0014","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jcyt.2016.03.295","article-title":"Off the shelf cellular therapeutics: factors to consider during cryopreservation and storage of human cells for clinical use","volume":"18","author":"Woods","year":"2016","journal-title":"Cytotherapy"},{"issue":"8","key":"10.1016\/j.jcyt.2025.102006_bib0015","doi-asserted-by":"crossref","first-page":"567.e1","DOI":"10.1016\/j.jtct.2025.03.018","article-title":"Hematopoietic stem cell (HSC) graft cryopreservation effects on outcomes of patients with hematologic malignancies: the multicenter united kingdom experience during the COVID-19 pandemic","volume":"31","author":"Barkauskiene","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jcyt.2025.102006_bib0016","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.bmt.1705462","article-title":"Has allogeneic stem cell cryopreservation been given the 'cold shoulder'? An analysis of the pros and cons of using frozen versus fresh stem cell products in allogeneic stem cell transplantation","volume":"38","author":"Frey","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.102006_bib0017","series-title":"cell engineering and regeneration, reference series in biomedical engineering","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-37076-7_68-2","article-title":"Preservation and storage of cells for therapy: current applications and protocols","author":"Acker","year":"2022"},{"issue":"2","key":"10.1016\/j.jcyt.2025.102006_bib0018","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cryobiol.2009.06.005","article-title":"Optimized cryopreservation method for human dental pulp-derived stem cells and their tissues of origin for banking and clinical use","volume":"59","author":"Woods","year":"2009","journal-title":"Cryobiology"},{"issue":"3","key":"10.1016\/j.jcyt.2025.102006_bib0019","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/152581603322023070","article-title":"A theoretically optimized method for cord blood stem cell cryopreservation","volume":"12","author":"Woods","year":"2003","journal-title":"J Hematother Stem Cell Res"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102006_bib0020","first-page":"3417","article-title":"The impact of varying cooling and thawing rates on the quality of cryopreserved human peripheral","volume":"9","author":"Baboo","year":"2019","journal-title":"Blood T Cells. Sci Rep."},{"issue":"3","key":"10.1016\/j.jcyt.2025.102006_bib0021","first-page":"213","article-title":"The ISHAGE guidelines for CD34+ cell determination by flow cytometry","volume":"5","author":"Sutherland","year":"1996","journal-title":"International Society of Hematotherapy and Graft Engineering. J Hematother."},{"key":"10.1016\/j.jcyt.2025.102006_bib0022","unstructured":"US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research; Regulatory considerations for human cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous use. https:\/\/www.fda.gov\/media\/109176\/download; 2020. [accessed 25.11.25]"},{"issue":"7","key":"10.1016\/j.jcyt.2025.102006_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.04.012","article-title":"Updated trends in hematopoietic cell transplantation in the United States with an additional focus on adolescent and young adult transplantation activity and outcomes","volume":"28","author":"Phelan","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jcyt.2025.102006_bib0024","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jcyt.2025.102006_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.09.003","article-title":"Bone marrow versus peripheral blood grafts for haploidentical hematopoietic cell transplantation with post-transplantation cyclophosphamide","volume":"27","author":"Mehta","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"16","key":"10.1016\/j.jcyt.2025.102006_bib0026","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-blood stem cells versus bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jcyt.2025.102006_bib0027","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1182\/bloodadvances.2016002766","article-title":"Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide","volume":"1","author":"Kasamon","year":"2017","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.jcyt.2025.102006_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(22)00184-3","article-title":"Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issues","volume":"9","author":"Worel","year":"2022","journal-title":"Lancet Haematol"},{"issue":"6","key":"10.1016\/j.jcyt.2025.102006_bib0029","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/bjh.14160","article-title":"Post-thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmes","volume":"174","author":"Morgenstern","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2025.102006_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2025.07.004","article-title":"Allogeneic hematopoietic cell donor selection: contemporary guidelines from the NMDP\/CIBMTR","author":"Jimenez Jimenez","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"9","key":"10.1016\/j.jcyt.2025.102006_bib0031","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/sj.bmt.1704926","article-title":"Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment","volume":"35","author":"Yang","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jcyt.2025.102006_bib0032","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000531236","article-title":"Predicting successful hematopoietic stem cell collection in healthy allogeneic donors","volume":"50","author":"Kayser","year":"2023","journal-title":"Transfus Med Hemother"},{"issue":"9","key":"10.1016\/j.jcyt.2025.102006_bib0033","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jtct.2024.06.002","article-title":"Scoping review of factors associated with stem cell mobilization and collection in allogeneic stem cell donors","volume":"30","author":"Peck","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"14","key":"10.1016\/j.jcyt.2025.102006_bib0034","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2016-11-752923","article-title":"Granulocyte colony-stimulating factor mobilizes dormant hematopoietic stem cells without proliferation in mice","volume":"129","author":"Bernitz","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jcyt.2025.102006_bib0035","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1182\/blood-2006-06-031401","article-title":"The chemokine GRObeta mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment","volume":"110","author":"Fukuda","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jcyt.2025.102006_bib0036","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1111\/jcmm.13539","article-title":"Effect of the in vivo application of granulocyte colony-stimulating factor on NK cells in bone marrow and peripheral blood","volume":"22","author":"Yu","year":"2018","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10.1016\/j.jcyt.2025.102006_bib0037","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CCO.0b013e32834f5c27","article-title":"Allogeneic transplantation: peripheral blood vs. bone marrow","volume":"24","author":"Bensinger","year":"2012","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102006_bib0038","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tmrv.2018.11.003","article-title":"Peripheral blood or bone marrow stem cells? Practical considerations in hematopoietic stem cell transplantation","volume":"33","author":"Amouzegar","year":"2019","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jcyt.2025.102006_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1403936","article-title":"Graft-versus-tumor effect of post-transplant cyclophosphamide-based allogeneic hematopoietic cell transplantation","volume":"15","author":"Nakamae","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2025.102006_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101093","article-title":"Relapse after allogeneic transplantation with post-transplant cyclophosphamide: Shattering myths and evolving insight","volume":"62","author":"McCurdy","year":"2023","journal-title":"Blood Rev"},{"issue":"2","key":"10.1016\/j.jcyt.2025.102006_bib0041","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2991\/chi.d.200221.001","article-title":"The CD34(+) cell dose matters in hematopoietic stem cell transplantation with peripheral blood stem cells from sibling donors","volume":"2","author":"Remberger","year":"2020","journal-title":"Clin Hematol Int"},{"issue":"4","key":"10.1016\/j.jcyt.2025.102006_bib0042","doi-asserted-by":"crossref","first-page":"211","DOI":"10.34172\/jcvtr.33230","article-title":"Post-transplant cyclophosphamide-induced cardiotoxicity: a comprehensive review","volume":"16","author":"Alizadehasl","year":"2024","journal-title":"J Cardiovasc Thorac Res"},{"issue":"4","key":"10.1016\/j.jcyt.2025.102006_bib0043","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1200\/JCO.21.02293","article-title":"Randomized phase III BMT CTN Trial of calcineurin inhibitor-free chronic graft-versus-host disease interventions in myeloablative hematopoietic cell transplantation for hematologic malignancies","volume":"40","author":"Luznik","year":"2022","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jcyt.2025.102006_bib0044","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1182\/blood.2021013054","article-title":"Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning","volume":"139","author":"McCurdy","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jcyt.2025.102006_bib0045","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1182\/bloodadvances.2020003005","article-title":"Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide","volume":"5","author":"Rambaldi","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102006_bib0046","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-022-01287-3","article-title":"Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant","volume":"15","author":"Zhao","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102006_bib0047","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14364","article-title":"Evaluation of the risk factors for BK virus-associated hemorrhagic cystitis in pediatric bone marrow transplantation patients: does post-transplantation cyclophosphamide increase the frequency?","volume":"27","author":"Ersoy","year":"2023","journal-title":"Pediatr Transplant"},{"issue":"23","key":"10.1016\/j.jcyt.2025.102006_bib0048","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1182\/blood.2020009362","article-title":"Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis","volume":"137","author":"Goldsmith","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102006_bib0049","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41409-023-02131-z","article-title":"Post-transplantation cyclophosphamide is associated with increased bacterial infections","volume":"59","author":"Ustun","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102006_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2023.09.017","article-title":"Incidence and impact of fungal infections in post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical hematopoietic cell transplantation: a center for international blood and marrow transplant research analysis","volume":"30","author":"Papanicolaou","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102006_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.09.015","article-title":"Post-transplantation cyclophosphamide is associated with an increase in non-cytomegalovirus herpesvirus infections in patients with acute leukemia and myelodysplastic syndrome","volume":"28","author":"Singh","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102006_bib0052","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/bjh.17563","article-title":"Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation","volume":"194","author":"Mulroney","year":"2021","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.jcyt.2025.102006_bib0053","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.bbmt.2018.12.142","article-title":"Higher incidence of hemorrhagic cystitis following haploidentical related donor transplantation compared with matched related donor transplantation","volume":"25","author":"Copelan","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jcyt.2025.102006_bib0054","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1182\/bloodadvances.2024014879","article-title":"Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation","volume":"9","author":"Hyder","year":"2025","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.jcyt.2025.102006_bib0055","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/j.1537-2995.2009.02180.x","article-title":"Long-term cryopreservation of autologous stem cell grafts: a clinical and experimental study of hematopoietic and immunocompetent cells","volume":"49","author":"Liseth","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2025.102006_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1382711","article-title":"Preservation of functionality, immunophenotype, and recovery of HIV RNA from PBMCs cryopreserved for more than 20 years","volume":"15","author":"Dyer","year":"2024","journal-title":"Front Immunol"},{"issue":"25","key":"10.1016\/j.jcyt.2025.102006_bib0057","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1200\/JCO-25-00856","article-title":"Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis after mismatched unrelated donor peripheral blood stem cell transplantation","volume":"43","author":"Al Malki","year":"2025","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jcyt.2025.102006_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2020.10.004","article-title":"Likelihood of proceeding to allogeneic hematopoietic cell transplantation in the united states after search activation in the national registry: impact of patient age, disease, and search prognosis","volume":"27","author":"Dehn","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"12","key":"10.1016\/j.jcyt.2025.102006_bib0059","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jtct.2022.09.015","article-title":"Trends in allogeneic hematopoietic cell transplantation utilization and estimated unmet need among Medicare beneficiaries with acute myelogenous leukemia","volume":"28","author":"Mau","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"5","key":"10.1016\/j.jcyt.2025.102006_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2024.02.012","article-title":"Factors associated with opting out of an unrelated hematopoietic stem cell donor registry: differences and similarities across five key groups of young race\/ethnically diverse potential donors in the United States","volume":"30","author":"Hamed","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102006_bib0061","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.transproceed.2022.10.057","article-title":"Worries and psychological well-being in potential hematopoietic stem cell donors before donation\u2014a Swedish National Study","volume":"55","author":"Winterling","year":"2023","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.jcyt.2025.102006_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.11.026","article-title":"Factors associated with opting out of donation among registered young unrelated hematopoietic stem cell donors","volume":"29","author":"Hamed","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"10.1016\/j.jcyt.2025.102006_bib0063","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/bmt.2012.54","article-title":"Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision","volume":"48","author":"Lown","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jcyt.2025.102006_bib0064","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/ajh.27084","article-title":"Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia","volume":"98","author":"Nath","year":"2023","journal-title":"Am J Hematol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324925009016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324925009016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:15:41Z","timestamp":1781334941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324925009016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1465324925009016"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.102006","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryopreserved organ donor bone marrow achieves robust engraftment and chimerism in mismatched allogeneic transplantation","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.102006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.102000","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102006"}}